Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo.

Kue CS, Lim HX, Jung MY, Hong HJ, Cho D, Kim TS.

Immunobiology. 2013 Jul;218(7):952-9. doi: 10.1016/j.imbio.2012.11.003. Epub 2012 Nov 21.

PMID:
23313049
2.

"Default" generation of neonatal regulatory T cells.

Wang G, Miyahara Y, Guo Z, Khattar M, Stepkowski SM, Chen W.

J Immunol. 2010 Jul 1;185(1):71-8. doi: 10.4049/jimmunol.0903806. Epub 2010 May 24.

3.

DNA methylation controls Foxp3 gene expression.

Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J.

Eur J Immunol. 2008 Jun;38(6):1654-63. doi: 10.1002/eji.200838105.

4.

Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.

Pletinckx K, Vaeth M, Schneider T, Beyersdorf N, Hünig T, Berberich-Siebelt F, Lutz MB.

Eur J Immunol. 2015 Feb;45(2):480-91. doi: 10.1002/eji.201444991. Epub 2014 Dec 2.

5.

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM.

J Exp Med. 2003 Dec 15;198(12):1875-86.

6.

Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.

Schliesser U, Chopra M, Beilhack A, Appelt C, Vogel S, Schumann J, Panov I, Vogt K, Schlickeiser S, Olek S, Wood K, Brandt C, Volk HD, Sawitzki B.

Eur J Immunol. 2013 Dec;43(12):3291-305. doi: 10.1002/eji.201243292. Epub 2013 Sep 9.

7.
8.

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x. Epub 2009 Jan 24.

9.

Integrated T-cell receptor and costimulatory signals determine TGF-β-dependent differentiation and maintenance of Foxp3+ regulatory T cells.

Gabryšová L, Christensen JR, Wu X, Kissenpfennig A, Malissen B, O'Garra A.

Eur J Immunol. 2011 May;41(5):1242-8. doi: 10.1002/eji.201041073. Epub 2011 Apr 11.

10.

Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.

Zhou Y, Salker MS, Walker B, Münzer P, Borst O, Gawaz M, Gulbins E, Singh Y, Lang F.

Cell Physiol Biochem. 2016;39(3):985-95. doi: 10.1159/000447806. Epub 2016 Aug 12.

11.

Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P, Borg C.

J Immunol. 2007 Dec 1;179(11):7593-604.

12.

Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells.

Oliveira VG, Caridade M, Paiva RS, Demengeot J, Graca L.

Eur J Immunol. 2011 May;41(5):1249-55. doi: 10.1002/eji.201040896.

13.

IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor.

Schuster M, Glauben R, Plaza-Sirvent C, Schreiber L, Annemann M, Floess S, Kühl AA, Clayton LK, Sparwasser T, Schulze-Osthoff K, Pfeffer K, Huehn J, Siegmund B, Schmitz I.

Immunity. 2012 Dec 14;37(6):998-1008. doi: 10.1016/j.immuni.2012.08.023. Epub 2012 Nov 29.

14.

Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.

Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B, Bommhardt UH.

J Immunol. 2009 Nov 15;183(10):6124-34. doi: 10.4049/jimmunol.0900246. Epub 2009 Oct 19.

15.

C6-ceramide enhances Interleukin-12-mediated T helper type 1 cell responses through a cyclooxygenase-2-dependent pathway.

Kue CS, Jung MY, Cho D, Kim TS.

Immunobiology. 2012 Jun;217(6):601-9. doi: 10.1016/j.imbio.2011.10.021. Epub 2011 Nov 3.

PMID:
22112438
16.

Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function.

Shevach EM, Davidson TS, Huter EN, Dipaolo RA, Andersson J.

J Clin Immunol. 2008 Nov;28(6):640-6. doi: 10.1007/s10875-008-9240-1. Epub 2008 Sep 23.

PMID:
18810612
17.

Setting the threshold for extra-thymic differentiation of Foxp3+ Tregs: TGF-β-dependent and T-cell autonomous.

Godkin A, Gallimore A.

Eur J Immunol. 2011 May;41(5):1218-20. doi: 10.1002/eji.201141576.

18.

Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.

Moore C, Sauma D, Morales J, Bono MR, Rosemblatt M, Fierro JA.

Transplant Proc. 2009 Jul-Aug;41(6):2670-2. doi: 10.1016/j.transproceed.2009.06.130.

PMID:
19715998
19.

Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.

Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, Neurath MF.

Gut. 2006 May;55(5):671-80. Epub 2005 Sep 14.

20.

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.

PMID:
17309822

Supplemental Content

Support Center